Correction

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

N Engl J Med 2000; 342:1376May 4, 2000

Article

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients (Original Article, N Engl J Med 2000:342;145 - 153) . On pages 152 and 153, in the Appendix, L. di Gerogio should be spelled L. De Giorgio, and S. La Tour should be F. La Tour.

Citing Articles (5)

Citing Articles

1. 1

   Kyle J Jeray, Stephanie Tanner, Emil H Schemitsch, Mohit Bhandari. (2010) Are Large Fracture Trials Possible?. Journal of Orthopaedic Trauma 24, S87-S92
   CrossRef

2. 2

   William R. Hiatt. 2008. Medical Treatment of Peripheral Arterial Disease. , 163-168.
   CrossRef

3. 3

   Michael Cuffe. (2006) The patient with cardiovascular disease: Treatment strategies for preventing major events. Clinical Cardiology 29:S2, 4-12
   CrossRef

4. 4

   James A. Reiffel. (2005) Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clinical Cardiology 28:S1, 28-37
   CrossRef

5. 5

   Gordon T McInnes. (2004) How important is optimal blood pressure control?. Clinical Therapeutics 26, A3-A11
   CrossRef